Open an Account
search icon
2
NOTIFICATIONS
Best Algo trading app in India
Bigul

TORRENT PHARMACEUTICALS LTD. - 500420 - Announcement under Regulation 30 (LODR)-Raising of Funds

 We would like to inform that the Board has at its meeting held today Recommended to members to obtain enabling approval for issuance of Equity Shares including Convertible Bonds / Debentures through Qualified Institutional Placement (QIP) and / or Depository Receipts or any other modes for an amount not exceeding Rs 5000 crores through Postal Ballot. The Copy of the Postal Ballot Notice etc., inter-alia, including the aforesaid proposal will be sent to you in due course.
27-01-2020
Bigul

TORRENT PHARMACEUTICALS LTD. - 500420 - Announcement under Regulation 30 (LODR)-Change in Directorate

 The Board has approved the re-appointment of Shri Samir Mehta as Executive Chairman of the Company for the period of 5 years effective from 01-Apr-20, subject to approval of the shareholders. His brief profile is enclosed herewith as Annexure - I. Shri Sudhir Mehta, Chairman Emeritus is relative of Shri Samir Mehta. Further, we would like to inform that Shri Mehta is not debarred from holding the office of director by virtue of any SEBI order or any other such authority. The above is for your information and record.
27-01-2020
Bigul

Torrent Pharmaceuticals Ltd - 500420 - Announcement under Regulation 30 (LODR)-Investor Presentation

 The presentation on unaudited Consolidated Financial Results for the quarter and nine months ended 31st December, 2019 to be made to analysts is enclosed for your records
27-01-2020
Bigul

TORRENT PHARMACEUTICALS LTD. - 500420 - Shareholding for the Period Ended December 31, 2019

 Torrent Pharmaceuticals Ltd has submitted to BSE the Shareholding Pattern for the Period Ended December 31, 2019. For more details, kindly Click here
20-01-2020
Bigul

Torrent Pharmaceuticals Ltd - 500420 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

 We hereby inform that the Company has scheduled a teleconference with Investors/ Analyst on 27th January, 2020 at 05:30 P.M: to discuss the financial performance of the Company for the quarter and nine months ended 31st December, 2019.
20-01-2020

Torrent Pharma to consider fund raising on Jan 27; share price hits 52-week high

 The company has fixed February 4 as the record date for the purpose of payment of interim dividend
16-01-2020

49 medicine samples fail regulator's quality tests

 A sample of Torrent Pharma's anti-hypertension drug Lorvas also failed the test.During the inspections in Dec, the CDSCO also found a counterfeit sample of Abbott India's Udiliv 300
15-01-2020
Bigul

Torrent Pharmaceuticals Ltd - 500420 - Intimation Of Record Date Pursuant To Regulation 42 Of The Securities & Exchange Board Of India (Listing Obligations And Disclosure Requirements) Regulations,2015 ("Listing Regulations")

 Pursuant to Regulation 42 of Listing Regulations, the Company has fixed Tuesday,04th February, 2020 as the Record Date for taking record of the Members of the Company for the purpose of payment of Interim Dividend, if declared by the Board at their meeting scheduled to be held on Monday, 27th January, 2020.
15-01-2020
Bigul

Torrent Pharmaceuticals Ltd - 500420 - Board to consider Q3 results & lnterim Dividend on Jan 27, 2020

 Torrent Pharmaceuticals Ltd has informed BSE that a meeting of the Board of Directors will be held on January 27, 2020, inter alia, to consider and approve the Audited Financial Results on Standalone basis and Unaudited Financial Results (with limited review) on Consolidated basis of the Company for the quarter and nine months ended on December 31, 2019 (Q3).In the above meeting, the Board would also consider the following:1. Payment of lnterim Dividend for the year 2019-20.2. Taking enabling resolutions for raising of funds by issue of Equity Shares including Convertible Bonds / Debentures through Qualified Institutional Placement (QIP) and / or Depository Receipts or any other modes. If such issue of Equity shares is approved by the Board of Directors, Shareholders' approval will be taken through postal ballot.
15-01-2020
Bigul

Torrent Pharmaceuticals Ltd - 500420 - Board Meeting Intimation for Intimation Of The Date Of Board Meeting Under Regulation 29 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015 ("Listing Regulations")

 TORRENT PHARMACEUTICALS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 27/01/2020 ,inter alia, to consider and approve 1. A meeting of the Board of Directors will be held on Monday, 27-Jan-20, inter alia to consider and approve the Audited Financial Results on Standalone basis and Unaudited Financial Results (with limited review) on Consolidated basis of the Company for the quarter and nine months ended on 31-Dec-19. 2. In the above meeting, the Board would also consider the following: i. Payment oflnterim Dividend for the year 2019-20. ii. . Taking enabling resolutions for raising of funds by issue of Equity Shares including Convertible Bonds / Debentures through Qualified Institutional Placement (QIP) and / or Depository Receipts or any other modes. If such issue of Equity shares is approved by the Board of Directors, Shareholders''approval will be taken through postal ballot. 1. A meeting of the Board of Directors will be held on Monday, 27-Jan-20, inter alia to consider and approve the Audited Financial Results on Standalone basis and Unaudited Financial Results (with limited review) on Consolidated basis of the Company for the quarter and nine months ended on 31-Dec-19. 2. In the above meeting, the Board would also consider the following: i. Payment oflnterim Dividend for the year 2019-20. ii. . Taking enabling resolutions for raising of funds by issue of Equity Shares including Convertible Bonds / Debentures through Qualified Institutional Placement (QIP) and / or Depository Receipts or any other modes. If such issue of Equity shares...
15-01-2020
Next Page
Close

Let's Open Free Demat Account